[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Generic_Tina Tina Banerjee
Tina Banerjee posts on X about sanofi, $8750t, $13b, gilead sciences the most. They currently have XX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Engagements: X #
- X Week XXX -XX%
- X Month XXX -XX%
- X Months XXXXX +111%
- X Year XXXXXX +327%
Mentions: X #
- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +55%
- X Year XXX +251%
Followers: XX #
- X Week XX -XXXX%
- X Month XX -XXXX%
- X Months XX +23%
CreatorRank: undefined #
Social Influence #
Social category influence stocks countries finance
Social topic influence sanofi #51, $8750t #19, $13b, gilead sciences, has been, hanmi pharm, japan, $4568t, $6417t, acquisition
Top assets mentioned Sanofi (SNY) Gilead Sciences, Inc. (GILD)
Top Social Posts #
Top posts by engagements in the last XX hours
"BeiGene reported strong 2Q25 revenues of $1.3B driven by Brukinsa sales in US and Europe. U.S. Brukinsa sales outpaced competitor for three consecutive quarters. Revenue guidance for 2025 increased"
X Link @Generic_Tina 2025-09-01T06:41Z XX followers, XX engagements
"CSPC Pharma got trial approval for Leqembi biosimilar. Celltrion is acquiring Lillys plant. Lotus Pharmaceutical is acquiring Alvogen US. Hengrui Pharma outlicensed Trastuzumab Rezetecan to Glenmark"
X Link @Generic_Tina 2025-09-28T00:35Z XX followers, XX engagements
"Daiichi Sankyos label expansion application for Enhertu has been accepted by FDA. Hanmi Pharm entered into global licensing agreement with Gilead Sciences. Boryung is acquiring Taxotere from Sanofi"
X Link @Generic_Tina 2025-10-05T00:35Z XX followers, XX engagements
"InnoCare stuck outlicensing deal with Zenas Bio. Daiichi Sankyo filed for label expansion of Enhertu in Japan. Celltrion got FDA nod for Eylea biosimilar. Lupin to build manufacturing plant in Florida"
X Link @Generic_Tina 2025-10-12T00:35Z XX followers, XX engagements
"Ono Pharmaceutical's Q1FY26 revenue increased X% YoY. Opdivo revenue decreased X% YoY due to competition. Despite indication expansion concerns remain over smaller addressable patient population"
X Link @Generic_Tina 2025-08-15T00:35Z XX followers, XX engagements
"Boryung Pharmaceutical is acquiringanti-cancer drug Taxotere from Sanofi for 175M. This deal marks the companys first acquisition of an originator anti-cancer drug across global territories"
X Link @Generic_Tina 2025-10-15T00:35Z XX followers, XX engagements